The Significance of Myelosuppression during Therapy with Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia in Chronic Phase

Thomas B. Sneed, Hagop M. Kantarjian, Moshe Talpaz, Susan O'Brien, Mary Beth Rios, B. Nebiyou Bekele, Xian Zhou, Debra Resta, William Wierda, Stefan Faderl, Francis Giles, Jorge E. Cortes

Research output: Contribution to journal › Article › peer-review

107 Scopus citations

Fingerprint

Dive into the research topics of 'The Significance of Myelosuppression during Therapy with Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia in Chronic Phase'. Together they form a unique fingerprint.

Medicine & Life Sciences